X4 Pharmaceuticals (XFOR) Misses Q1 EPS by 12c
X4 Pharmaceuticals (NASDAQ: XFOR) reported Q1 EPS of ($0.26), $0.12 worse than the analyst estimate of ($0.14).
For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.
X4 Pharmaceuticals (NASDAQ: XFOR) reported Q1 EPS of ($0.26), $0.12 worse than the analyst estimate of ($0.14).
For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.